↩ Go Back
Need help?

Specialty Pharmaceuticals Company Investment Opportunity in Visakhapatnam, India

New biopharmaceutical company with a primary focus on plasma fractionation to manufacture therapeutic plasma proteins.
This Business is on a Premium Plan
Established 1-5 year(s)
Employees 10 - 50
Legal Entity Private Limited Company
Reported Sales Nil
Run Rate Sales Nil
EBITDA Margin Nil
Industries Specialty Pharmaceuticals
Locations  Visakhapatnam
Local Time 5:03 PM America / Chicago
Listed By Management Member
Status Active
Overall Rating
Partial Stake Sale
USD 4 million for 10.0% stake (Native Currency: USD 4,000,000)
Reason: ▪ Construction of 150,000 sq ft manufacturing plant. With a capacity to fractionate up to 200,000 l... View More
Includes physical assets worth USD 25 million
Interested to connect with advisors
Name, Phone, Email
Not disclosed
Business Name
Not disclosed
User Verification
Documents
Business Overview

● Our business has already obtained DCGI approval to manufacture the following proteins in the R&D Unit for the purpose of research and analysis.

● Our R&D unit is set up in 2,000 sq ft space in MN iHub, GenomeValley, Turkapally, Hyderabad with 3 state-of-the-art designated lab spaces for process development, analytical R&D and quality control with a total of 25 staff members.

● Our protein samples are already been extracted and stability studies are being done.

● 150,000 sq ft manufacturing facility is under contraction and will be completed soon.

● By the time the business starts operations, we will have 200 employees.

● Founders are based in the US.

Products & Services Overview

We will manufacture plasma proteins such as albumin, intravenous gamma globulins (IVIG), Factor IX, Factor VIII, and Fibrin sealant for health centers.

Assets Overview

Tangible assets are our product samples, equipment, civil infrastructure and land.

Intangibles- Excellent team of physicians as founders, Executive team with a combined experience of 100 years, our collective vision and passion.

Facilities Overview

R&D unit located in 2,000 sq ft rented space Genome Valley, Turkapally, Hyderabad has 3 designated lab spaces for process development, analytical R&D and quality control.

Under construction of 150,000 sq ft manufacturing plant with a capacity to fractionate up to 200,000 liters of plasma per year.

Under construction of 30,000 sq ft administration block and cafeteria.

Setting up cold storage and establishing logistics for plasma procurement.

Facility is being constructed on our own land.

Around 30% of the construction has been completed.

Capitalization Overview

Rs 20 crores founders- seed money.

Rs 20 crore Govt of India 0% loan under make in India.

Rs 15 crores family and friends.

Rs 110 crore loan National bank.

Business has 4 founders.

Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business

9 Investors viewed this Business this month.
Register below to connect now!

Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

    Frequently
    Asked
    Questions

    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more